Computational Modeling of Drugs Against Alzheimer’s Disease (Neuromethods, Vol. 132) '17
目次
Preface…Table of Contents…Contributing Authors…Part I An Introduction to the Disease1. Alzheimer’s Disease Therapy: Present and Future MoleculesAwanish Kumar and Ashwini KumarPart II Computational Modeling Methods for Anti-Alzheimer Agents2. Recent Advances in Computational Approaches for Designing Potential Anti-Alzheimer’s AgentsSergi Gómez-Ganau, Jesús Vicente de Julián Ortiz, and Rafael Gozalbes3. Computer-Aided Drug Design Approaches to Study Key Therapeutic Targets in Alzheimer’s DiseaseAgostinho Lemos, Rita Melo, Irina S. Moreira and M. Natália D. S. Cordeiro4. Virtual Screening in the Search of New and Potent Anti-Alzheimer AgentsLivia Basile 5. Molecular Field Topology Analysis (MFTA) in the Design of Neuroprotective CompoundsEugene V. Radchenko, Vladimir A. Palyulin, and Nikolay S. ZefirovPart III Modeling of Ligands Acting against Specific Anti-Alzheimer Drug Targets 6. Galantamine Derivatives as Acetylcholinesterase Inhibitors: Docking, Design, Synthesis, and Inhibitory ActivityIrini Doytchinova, Mariyana Atanasova, Georgi Stavrakov, Irena Philipova, and Dimitrina Zheleva-Dimitrova7. Modeling of BACE-1 Inhibitors as Anti-Alzheimer’s AgentsOdailson Santos Paz, Thamires Quadros Froes, Franco Henrique Leite, and Marcelo Santos Castilho8. Design of Anti-Alzheimer’s Disease Agents Focusing on a Specific Interaction with Target Biomolecules11. Computational Approaches to Understand Cleavage Mechanism of Amyloid Beta (Aβ) PeptideKailas Dashrath Sonawane and Maruti Jayaram Dhanavade12. Computational Modeling of Gamma-Secretase Inhibitors as Anti-Alzheimer AgentsPrabu Manoharan and Nanda Ghoshal13. Molecular Modeling of Tau Proline-Directed Protein Kinase (PDPK) InhibitorsCarlos Navarro-Retamal and Julio Caballero14. Computational Modeling of Kinase Inhibitors as Anti-Alzheimer AgentsMange Ram Yadav, Mahesh A. Barmade, Rupesh V. Chikhale, and Prashant R. Murumkar15. Computational Modeling of Drugs for Alzheimer's Disease: Design of Serotonin 5-HT6 AntagonistsÁdám A Kelemen, Stefan Mordalski, Andrzej J Bojarski, and György M Keserű16. Computational Modeling of Diagnostic Imaging Agents for Alzheimer's Disease: Molecular Imaging Agents for the In Vivo Detection of Amyloid Plaques in Alzheimer’s DiseasePapagiannopoulou Dionysia and Hadjipavlou-Litina DimitraPart IV Special Topics17. Computational Approaches for Therapeutic Application of Natural Products in Alzheimer’s DiseaseManika Awasthi, Swati Singh, Sameeksha Tiwari, Veda P. Pandey, and Upendra N. Dwivedi18. In Silico Studies Applied to Natural Products with Potential Activity against Alzheimer’s DiseaseLuciana Scotti and Marcus T. Scotti19. Computational Modeling of Multi-Target Directed Inhibitors against Alzheimer's DiseaseAkhil Kumar and Ashok Sharma20. Neuropharmacology in Flux: Molecular Modeling Tools for Understanding Protein Conformational Shifts in Alzheimer’s Disease and Related DisordersGerald H. Lushington, Frances E.S. Parker, Thomas H.W. Lushington, and Nora M. Wallace21. Computational Nanotechnology: A Tool for Screening Therapeutic Nanomaterials against Alzheimer's DiseaseR. Navanietha Krishnaraj, Dipayan Samanta, and Rajesh K. Sani
カート
カートに商品は入っていません。